DementiaLENDNCT07757178
Lived Experience Narratives in Dementia
A study testing Online LEND Intervention in people with Dementia and Neuro-Degenerative Disease, run by University of Nottingham at 2 sites in United Kingdom.
Trial summary
The Lived Experience Narratives in Dementia (LEND) research programme involves five work packages (WP). WP1 explores how people living with dementia use narratives and how narratives can impact them. Findings will support the development of LEND theory. Read more about this study
- Who is it for?
- Ages 18 to 99 yearsHealthy volunteers can take part
- Conditions the study is for
- Dementia, Neuro-Degenerative Disease, Alzheimer Disease
- What is being tested?
- Online LEND Intervention
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 2 sitesUnited Kingdom
- Study dates
- 17 Nov 2025to Jul 2029
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 99 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
General Inclusion Criteria (apply across WP1-WP3)
- Adults aged 18+.
- Able to give informed consent and participate meaningfully in the required tasks.
- Adequate communication ability in the required study language
General Exclusion Criteria (apply across WP1-3)
- Living in a hospital or healthcare institution at the time of the study.
- Refusal or inability to provide informed consent, or lack of capacity to consent.
- Inability to comprehend participant information or communicate meaningfully
Trial locations and contacts
2 sites in 1 country. Contact the study team or a site near you to ask about taking part.
Mark Howells contact
United Kingdom2 sites, 2 recruiting
- Recruiting
Mental Health & Clinical Neurosciences, Institute of Mental Health
Nottingham, England, NG7 2TU
Martin Orrell, Director of IMH & LEND CI, 0115 823 1294, M.Orrell@nottingham.ac.uk
Linda O'Raw, LEND Programme Manager, 07791598280, linda.o'raw@nottingham.ac.uk
- Recruiting
Nottinghamshire Healthcare NHS Foundation , Highbury Hospital
Nottingham, NG6 9DR
Mark Howells, Sponsor, 0115 969 1300, mark.howells@nottshc.nhs.uk
About this study
Official title: Improving the Quality of Life for People Living With Dementia and Carers: The Design and Development of a Dementia Specific Online Narrative-Based Intervention With a Feasibility Study
The Lived Experience Narratives in Dementia (LEND) research programme involves five work packages (WP). WP1 explores how people living with dementia use narratives and how narratives can impact them. Findings will support the development of LEND theory. WP 2-3 focus on developing the digital Online LEND Intervention, assessing its usability and acceptability, and conducting a feasibility study within NHS memory assessment and community services. Activities across the first three WPs include interviews, focus groups, user-testing sessions, engagement evaluation interviews, and a two-arm randomised feasibility trial using a range of outcome measures. Findings from this stage will inform refinement of the intervention and determine the feasibility of progressing to a future randomised controlled trial (RCT) of the Online LEND Intervention. WP4 is the Online LEND Intervention two-arm RCT. WP5 involves dissemination. The protocol for WP4 and 5 have not yet been developed and rely on results from WP1-3.
Read the detailed description
Study Overview The Lived Experience Narratives in Dementia (LEND) Programme is a five-year NIHR-funded research programme designed to develop, optimise, and evaluate a novel digital intervention that delivers personalised lived-experience narratives to people living with dementia and their carers. The ultimate goal is to improve wellbeing and quality of life by providing accessible, relatable, and culturally diverse narratives that promote hope, self-efficacy, independence, and emotional support.
Packages (WP) 1-3, includes theory development (WP1), intervention development (WP2), and a randomised controlled feasibility study with long-term follow-up interviews (WP3).
LEND prioritises inclusion of under-served communities, including Black and South Asian groups, LGBT+ communities, people with young-onset dementia, and people with rarer dementias (see LEND WP1-3 Protocol v1.0 CLEAN).
WORK PACKAGE 1: Development of LEND Theory WP1 develops the theoretical foundations that shape the design and content of the LEND digital intervention. It consists of five interconnected sub-work packages, each addressing a different element of user experience, narrative relevance, and contextual factors affecting engagement.
WP1.1: Online or Paper Survey (WP1.1O / WP1.1P) Purpose: To understand how people living with dementia and carers use social media, technology, and online resources over time.
Design: A continuous cross-sectional survey, recruiting ≥300 participants per year over five years (minimum n=1,500 total) LEND WP1-3 Protocol v1.0 CLEAN
Focus:
- Patterns of online behaviour
- Barriers and facilitators to digital engagement
- Types of narratives accessed, preferred formats, and comfort levels with online content
WP1.2: Semi-Structured Interviews Purpose: To explore how lived-experience narratives may benefit people living with dementia and carers, informing LEND theory.
Sample: n=30 (15 people with dementia; 15 carers) LEND WP1-3 Protocol v1.0 CLEAN
Focus:
- Perceived use and impact of narratives
- Digital literacy, accessibility, and digital poverty
WP1.3a: Narrative Impact Validation Purpose: To test how participants engage with up to five lived-experience narratives selected from an initial pool of ~30 narratives, including those from ethnic minority and under-served groups.
Sample: n=40 (20 people with dementia; 20 carers) LEND WP1-3 Protocol v1.0 CLEAN
Focus:
- Emotional and cognitive responses to narratives
- Comprehension, resonance, and perceived relevance
- The development of criteria
- Safety considerations (e.g., triggering material, content warnings)
WP1.3b: Narrative Rating Purpose: To develop a categorisation framework for dementia narratives based on user ratings and feedback.
Sample: Repeat measures from WP1.3a.
Focus:
- Narrative qualities (tone, genre, turning points, themes)
- Degree of helpfulness, clarity, relatability
- Score or rate different types of narrative
- User preferences to inform algorithmic recommendations
WP1.4: Focus Groups Purpose: Conducted in collaboration with the Centre for Ethnic Health Research, WP1.4 prioritises inclusion of Black, South Asian, and other under-served communities.
Sample: Four focus groups (n=40 total) LEND WP1-3 Protocol v1.0 CLEAN
Focus:
- Cultural perceptions of dementia
- Barriers to accessing support and digital interventions
- Relevance, acceptability, and cultural safety of narratives
WP1.5: Discrete Choice Experiment (DCE) Purpose: To determine which narrative features are most valued by people with dementia, carers, and the general public.
Sample:
- n=10 people with dementia
- n=10 carers
- n=10 general public LEND WP1-3 Protocol v1.0 CLEAN
Focus:
- Trade-offs between different narrative types
- Preferences relating to narrator characteristics, narrative tone, format, and content
- Input directly informing later intervention design
WORK PACKAGE 2: Development of LEND Intervention WP2 focuses on building the digital intervention through iterative, user-centred development.
WP2.3: Development of the LEND Digital Intervention WP2.3 is a multi-phase iterative development process consisting of workshops, prototype development, usability testing, accessibility refinement, and preparation for feasibility evaluation.
Phase 1: Co-production Workshops (Months 10-12)
Using LEAP (Lived Experience Advisory Panel) members and developers:
- Identify essential features of the LEND Portal and Online LEND Intervention
- Determine accessibility requirements and inclusive design priorities Phase 2: First Working Version (Months 12-14)
- Build initial prototype of the LEND web application
- Conduct first stage of usability testing with n=20 participants (10 carers, 10 people with dementia)
- Develop expert rules for relevance-based narrative retrieval Phase 3: Second Working Version \& Testing (Months 14-18)
- Refine interface based on feedback
- Achieve AA-level accessibility compliance (WCAG \& EN 301 549)
- Conduct second usability testing cycle with n=20 (balanced sample) Phase 4: Third Working Version (Months 18-36)
- Produce pre-feasibility version of intervention
- Conduct in-vivo user testing
- Recruit from earlier phases to conduct extended testing
Key Features of Intervention (developed across WP2.3):
- Web-based LEND Portal (registration, consent, outcome measures)
- Machine-learning narrative recommender
- Narrative filtering and content warnings
- Ability to rate, block, or bookmark narratives
- Optional LEND eBooklet for digital inclusion (low-tech video player) All narratives used are categorised using the INCRESE-D system developed in WP2.1 and curated into the LEND Collection (WP2.2).
WORK PACKAGE 3: Feasibility Study and Long-Term Impact WP3 evaluates feasibility, acceptability, and preliminary signals of impact in preparation for a full-scale RCT.
WP3.1: Randomised Controlled Feasibility Study
Design:
- Parallel-group RCT with 1:1 randomisation
- Intervention (Online LEND Intervention) vs. Treatment as Usual (TAU)
- Stratified by co-resident carer status
- Remote computerised randomisation via Bangor Clinical Trials Unit
- Analysts blinded to allocation Sample: n=60
- 30 people with dementia
- 30 carers Duration: 6-month follow-up period
Outcome Measures (all self-report via LEND Portal):
Primary outcomes include:
- QoL-AD (PWoD only)
- SWEMWBS (both groups)
Secondary outcomes include:
- EID-Q, RSES, GSES, CSES, Zarit Burden, EQ-5D-5L, ICECAP-O, Adult Hope Scale, CSRI
Feasibility Outcomes:
- Recruitment rates and retention
- Adherence and engagement with intervention (time spent, narratives accessed)
- Acceptability and suitability of intervention in real-world contexts
- Data completeness and technical viability of digital data collection
WP3.2: Long-Term Impact Interviews Purpose: To evaluate longer-term influence of the LEND intervention among those who received it in WP3.1.
Sample: n=20
- 10 people with dementia
- 10 carers
Timing:
- 12 months post-randomisation
- 18 months post-randomisation
Focus:
- Sustained changes in wellbeing, confidence, independence, and support
- Usability, acceptability, suitability over longer durations
- Experiences with platform features and narrative engagement
- Identification of risks, barriers, or unintended consequences Interviews are recorded, transcribed, and linked to participants' engagement and demographic data using a pseudonymised UID system
Integrated Purpose of WP1-3
Collectively, these work packages:
- Establish the theoretical foundation (WP1)
- Develop a user-centred and accessible digital intervention (WP2)
- Evaluate feasibility, acceptability, and preliminary outcomes required for a future fully powered clinical trial (WP3) This integrated, iterative design follows the MRC Framework for Developing and Evaluating Complex Interventions (2021) and aligns with NICE digital technology evidence standards.
WP4 and WP5 will be determined following the evaluation of WP1-3.
- Conditions
- Dementia, Neuro-Degenerative Disease, Alzheimer Disease, Caregiver Burden, Caregiver Burnout
- Being tested
- Online LEND Intervention
- Medical subject headings
- Dementia, Alzheimer Disease, Caregiver Burden
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Online LEND InterventionBehavioural
The Online LEND Intervention is a web-based platform that provides personalised lived-experience narratives for people with dementia and their carers. It aims to support wellbeing, confidence, and self-efficacy by offering relatable stories from others with similar experiences. The final design is still in development but is expected to include personalised recommendations, simplified navigation, adjustable text, audio playback, captioning, and content warnings. Users will be able to bookmark, rate, or hide stories and access the intervention independently at home over a 4 to 6-week period. The platform will be accessed via the secure LEND Portal, where participants also complete study measures. LEND does not provide clinical advice; it offers supportive, ethically reviewed narratives to promote connection and empowerment.
| Study group | Role | What they receive |
|---|---|---|
| Online LEND Intervention | Experimental | Participants in WP3, the feasibility trial, are allocated to this arm receive access to the LEND digital intervention. The intervention consists of a web-based platform that provides personalised lived-experience narratives curated for people with dementia and their family carers. Content includes written, audio, and video narratives covering themes such as coping strategies, identity, emotions, daily living, social relationships, and adjusting to diagnosis.
Participants are able to browse and select narratives; receive recommendations based on preferences; bookmark or rate content; and use accessibility features designed to support cognitive needs, including simplified navigation, adjustable text, and audio playback. The intervention is used independently at home for 4 to 6 weeks, with no minimum usage requirement.
Participants also complete baseline and follow-up outcome measures through the integrated LEND Portal prior to randomisation. Receives: Behavioral: Online LEND Intervention |
| Treatment as Usual | No intervention | Participants randomised to this arm continue to receive their standard care and support as normally provided. This may include by NHS Memory Assessment Services, community mental health teams, primary care, and other relevant voluntary-sector and non voluntary-sector organisations. They do not receive access to the Online LEND Intervention during the feasibility study period. Prior to randomisation, participants complete the same baseline outcome measures. Access to the LEND portal, but not the Online LEND Intervention, is continued as follow-up outcome measures are required after 6 months period, paralleling the intervention arm. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Quality of Life (QoL-AD)
The Quality of Life in Alzheimer's Disease (QoL-AD) scale is a validated measure captures wellbeing across multiple domains including mood, relationships, daily activities, memory, and overall life satisfaction. The feasibility study will assess completeness of data, variability, and acceptability of QoL-AD as the primary endpoint for a future definitive RCT.
Measured: Baseline and Six Months
Mental Wellbeing (SWEMWBS)
The Short Warwick-Edinburgh Mental Wellbeing Scale (SWEMWBS). This seven-item scale assesses emotional functioning, optimism, and psychological wellbeing. The feasibility study will evaluate suitability, recruitment, retention, and response characteristics of SWEMWBS as the primary carer outcome for the full trial.
Measured: Baseline and Six Months
Secondary outcomes (2)
Engagement and Independence in Dementia Questionnaire (EID-Q)
For people with dementia only. Assesses engagement in meaningful activities, independence, autonomy, and perceived capabilities in daily life.
Measured: Baseline and Six Months
Rosenberg Self-Esteem Scale - Brief Version (RSES)
For both people with dementia and family carers. Measure of global self-esteem and self-worth.
Measured: Baseline and Six Months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Aug 2026
- Study start17 Nov 2025
- Primary completionMar 2029 (estimated)
- Study completionJul 2029 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for DementiaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- In WP3, this study uses a two-arm parallel-group randomised feasibility design in which participants are allocated 1:1 to either the Online LEND Intervention or a Treatment-as-Usual (TAU) control group. The purpose of the design is not to test clinical effectiveness but to evaluate the feasibility and acceptability of trial procedures, including recruitment, randomisation, retention, data collection, participant engagement, and outcome measure completion. Randomisation is stratified by whether the person with dementia has a co-resident carer, and allocation is performed using a secure, automated computerised system managed by the Bangor Clinical Trials Unit. Analysts and outcome assessors are blinded to group allocation. The results of this feasibility randomised trial will be used to inform the design and delivery of a future fully powered randomised controlled trial.
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Nottingham
- Sponsor type
- University, hospital or other
- Collaborators
- Nottinghamshire Healthcare NHS Trust
- Responsible party
- Sponsor
- Investigators
- Martin Orrell, Study director, University of Nottingham
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07757178
- Sponsor's protocol ID
- IRAS351969
- Other IDs
- NIHR206255
- Acronym
- LEND
- Status last verified
- Nov 2025
- First submitted
- 28 Jul 2026
- Last updated
- 11 Aug 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Only anonymised data will be shared for the purposes of analysis and interpretation.
Study at a glance
From the registry record, last updated by the sponsor on 11 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Improving the Quality of Life for People Living With Dementia and Carers: The Design and Development of a Dementia Specific Online Narrative-Based Intervention With a Feasibility Study
- ClinicalTrials.gov ID
- NCT07757178
- Acronym / sponsor ID
- LEND / IRAS351969
- Conditions
- Dementia, Neuro-Degenerative Disease, Alzheimer Disease, Caregiver Burden, Caregiver Burnout
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- University of NottinghamUniversity, hospital or other
- Collaborators
- Nottinghamshire Healthcare NHS Trust
- Study start
- 17 Nov 2025 (actual)
- Primary completion
- Mar 2029 (estimated)
- Study completion
- Jul 2029 (estimated)
- First posted
- 11 Aug 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The Lived Experience Narratives in Dementia (LEND) research programme involves five work packages (WP). WP1 explores how people living with dementia use narratives and how narratives can impact them. Findings will support the development of LEND theory. WP 2-3 focus on developing the digital Online LEND Intervention, assessing its usability and acceptability, and conducting a feasibility study within NHS memory assessment and community services. Activities across the first three WPs include interviews, focus groups, user-testing sessions, engagement evaluation interviews, and a two-arm randomised feasibility trial using a range of outcome measures. Findings from this stage will inform refinement of the intervention and determine the feasibility of progressing to a future randomised controlled trial (RCT) of the Online LEND Intervention. WP4 is the Online LEND Intervention two-arm RCT. WP5 involves dissemination. The protocol for WP4 and 5 have not yet been developed and rely on results from WP1-3.
Detailed description
Study Overview The Lived Experience Narratives in Dementia (LEND) Programme is a five-year NIHR-funded research programme designed to develop, optimise, and evaluate a novel digital intervention that delivers personalised lived-experience narratives to people living with dementia and their carers. The ultimate goal is to improve wellbeing and quality of life by providing accessible, relatable, and culturally diverse narratives that promote hope, self-efficacy, independence, and emotional support.
Packages (WP) 1-3, includes theory development (WP1), intervention development (WP2), and a randomised controlled feasibility study with long-term follow-up interviews (WP3).
LEND prioritises inclusion of under-served communities, including Black and South Asian groups, LGBT+ communities, people with young-onset dementia, and people with rarer dementias (see LEND WP1-3 Protocol v1.0 CLEAN).
WORK PACKAGE 1: Development of LEND Theory WP1 develops the theoretical foundations that shape the design and content of the LEND digital intervention. It consists of five interconnected sub-work packages, each addressing a different element of user experience, narrative relevance, and contextual factors affecting engagement.
WP1.1: Online or Paper Survey (WP1.1O / WP1.1P) Purpose: To understand how people living with dementia and carers use social media, technology, and online resources over time.
Design: A continuous cross-sectional survey, recruiting ≥300 participants per year over five years (minimum n=1,500 total) LEND WP1-3 Protocol v1.0 CLEAN
Focus:
- Patterns of online behaviour
- Barriers and facilitators to digital engagement
- Types of narratives accessed, preferred formats, and comfort levels with online content
WP1.2: Semi-Structured Interviews Purpose: To explore how lived-experience narratives may benefit people living with dementia and carers, informing LEND theory.
Sample: n=30 (15 people with dementia; 15 carers) LEND WP1-3 Protocol v1.0 CLEAN
Focus:
- Perceived use and impact of narratives
- Digital literacy, accessibility, and digital poverty
WP1.3a: Narrative Impact Validation Purpose: To test how participants engage with up to five lived-experience narratives selected from an initial pool of ~30 narratives, including those from ethnic minority and under-served groups.
Sample: n=40 (20 people with dementia; 20 carers) LEND WP1-3 Protocol v1.0 CLEAN
Focus:
- Emotional and cognitive responses to narratives
- Comprehension, resonance, and perceived relevance
- The development of criteria
- Safety considerations (e.g., triggering material, content warnings)
WP1.3b: Narrative Rating Purpose: To develop a categorisation framework for dementia narratives based on user ratings and feedback.
Sample: Repeat measures from WP1.3a.
Focus:
- Narrative qualities (tone, genre, turning points, themes)
- Degree of helpfulness, clarity, relatability
- Score or rate different types of narrative
- User preferences to inform algorithmic recommendations
WP1.4: Focus Groups Purpose: Conducted in collaboration with the Centre for Ethnic Health Research, WP1.4 prioritises inclusion of Black, South Asian, and other under-served communities.
Sample: Four focus groups (n=40 total) LEND WP1-3 Protocol v1.0 CLEAN
Focus:
- Cultural perceptions of dementia
- Barriers to accessing support and digital interventions
- Relevance, acceptability, and cultural safety of narratives
WP1.5: Discrete Choice Experiment (DCE) Purpose: To determine which narrative features are most valued by people with dementia, carers, and the general public.
Sample:
- n=10 people with dementia
- n=10 carers
- n=10 general public LEND WP1-3 Protocol v1.0 CLEAN
Focus:
- Trade-offs between different narrative types
- Preferences relating to narrator characteristics, narrative tone, format, and content
- Input directly informing later intervention design
WORK PACKAGE 2: Development of LEND Intervention WP2 focuses on building the digital intervention through iterative, user-centred development.
WP2.3: Development of the LEND Digital Intervention WP2.3 is a multi-phase iterative development process consisting of workshops, prototype development, usability testing, accessibility refinement, and preparation for feasibility evaluation.
Phase 1: Co-production Workshops (Months 10-12)
Using LEAP (Lived Experience Advisory Panel) members and developers:
- Identify essential features of the LEND Portal and Online LEND Intervention
- Determine accessibility requirements and inclusive design priorities Phase 2: First Working Version (Months 12-14)
- Build initial prototype of the LEND web application
- Conduct first stage of usability testing with n=20 participants (10 carers, 10 people with dementia)
- Develop expert rules for relevance-based narrative retrieval Phase 3: Second Working Version \& Testing (Months 14-18)
- Refine interface based on feedback
- Achieve AA-level accessibility compliance (WCAG \& EN 301 549)
- Conduct second usability testing cycle with n=20 (balanced sample) Phase 4: Third Working Version (Months 18-36)
- Produce pre-feasibility version of intervention
- Conduct in-vivo user testing
- Recruit from earlier phases to conduct extended testing
Key Features of Intervention (developed across WP2.3):
- Web-based LEND Portal (registration, consent, outcome measures)
- Machine-learning narrative recommender
- Narrative filtering and content warnings
- Ability to rate, block, or bookmark narratives
- Optional LEND eBooklet for digital inclusion (low-tech video player) All narratives used are categorised using the INCRESE-D system developed in WP2.1 and curated into the LEND Collection (WP2.2).
WORK PACKAGE 3: Feasibility Study and Long-Term Impact WP3 evaluates feasibility, acceptability, and preliminary signals of impact in preparation for a full-scale RCT.
WP3.1: Randomised Controlled Feasibility Study
Design:
- Parallel-group RCT with 1:1 randomisation
- Intervention (Online LEND Intervention) vs. Treatment as Usual (TAU)
- Stratified by co-resident carer status
- Remote computerised randomisation via Bangor Clinical Trials Unit
- Analysts blinded to allocation Sample: n=60
- 30 people with dementia
- 30 carers Duration: 6-month follow-up period
Outcome Measures (all self-report via LEND Portal):
Primary outcomes include:
- QoL-AD (PWoD only)
- SWEMWBS (both groups)
Secondary outcomes include:
- EID-Q, RSES, GSES, CSES, Zarit Burden, EQ-5D-5L, ICECAP-O, Adult Hope Scale, CSRI
Feasibility Outcomes:
- Recruitment rates and retention
- Adherence and engagement with intervention (time spent, narratives accessed)
- Acceptability and suitability of intervention in real-world contexts
- Data completeness and technical viability of digital data collection
WP3.2: Long-Term Impact Interviews Purpose: To evaluate longer-term influence of the LEND intervention among those who received it in WP3.1.
Sample: n=20
- 10 people with dementia
- 10 carers
Timing:
- 12 months post-randomisation
- 18 months post-randomisation
Focus:
- Sustained changes in wellbeing, confidence, independence, and support
- Usability, acceptability, suitability over longer durations
- Experiences with platform features and narrative engagement
- Identification of risks, barriers, or unintended consequences Interviews are recorded, transcribed, and linked to participants' engagement and demographic data using a pseudonymised UID system
Integrated Purpose of WP1-3
Collectively, these work packages:
- Establish the theoretical foundation (WP1)
- Develop a user-centred and accessible digital intervention (WP2)
- Evaluate feasibility, acceptability, and preliminary outcomes required for a future fully powered clinical trial (WP3) This integrated, iterative design follows the MRC Framework for Developing and Evaluating Complex Interventions (2021) and aligns with NICE digital technology evidence standards.
WP4 and WP5 will be determined following the evaluation of WP1-3.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
- Model description
- In WP3, this study uses a two-arm parallel-group randomised feasibility design in which participants are allocated 1:1 to either the Online LEND Intervention or a Treatment-as-Usual (TAU) control group. The purpose of the design is not to test clinical effectiveness but to evaluate the feasibility and acceptability of trial procedures, including recruitment, randomisation, retention, data collection, participant engagement, and outcome measure completion. Randomisation is stratified by whether the person with dementia has a co-resident carer, and allocation is performed using a secure, automated computerised system managed by the Bangor Clinical Trials Unit. Analysts and outcome assessors are blinded to group allocation. The results of this feasibility randomised trial will be used to inform the design and delivery of a future fully powered randomised controlled trial.
| Arm | Type | Receives |
|---|---|---|
| Online LEND Intervention | Experimental | Behavioral: Online LEND InterventionParticipants in WP3, the feasibility trial, are allocated to this arm receive access to the LEND digital intervention. The intervention consists of a web-based platform that provides personalised lived-experience narratives curated for people with dementia and their family carers. Content includes written, audio, and video narratives covering themes such as coping strategies, identity, emotions, daily living, social relationships, and adjusting to diagnosis. Participants are able to browse and select narratives; receive recommendations based on preferences; bookmark or rate content; and use accessibility features designed to support cognitive needs, including simplified navigation, adjustable text, and audio playback. The intervention is used independently at home for 4 to 6 weeks, with no minimum usage requirement. Participants also complete baseline and follow-up outcome measures through the integrated LEND Portal prior to randomisation. |
| Treatment as Usual | No intervention | –Participants randomised to this arm continue to receive their standard care and support as normally provided. This may include by NHS Memory Assessment Services, community mental health teams, primary care, and other relevant voluntary-sector and non voluntary-sector organisations. They do not receive access to the Online LEND Intervention during the feasibility study period. Prior to randomisation, participants complete the same baseline outcome measures. Access to the LEND portal, but not the Online LEND Intervention, is continued as follow-up outcome measures are required after 6 months period, paralleling the intervention arm. |
Who may qualify
- Ages
- 18 to 99 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Online LEND InterventionThe Online LEND Intervention is a web-based platform that provides personalised lived-experience narratives for people with dementia and their carers. It aims to support wellbeing, confidence, and self-efficacy by offering relatable stories from others with similar experiences. The final design is still in development but is expected to include personalised recommendations, simplified navigation, adjustable text, audio playback, captioning, and content warnings. Users will be able to bookmark, rate, or hide stories and access the intervention independently at home over a 4 to 6-week period. The platform will be accessed via the secure LEND Portal, where participants also complete study measures. LEND does not provide clinical advice; it offers supportive, ethically reviewed narratives to promote connection and empowerment. | Behavioural | Online LEND Intervention |
Primary outcome
Quality of Life (QoL-AD)
Time frame: Baseline and Six Months
The Quality of Life in Alzheimer's Disease (QoL-AD) scale is a validated measure captures wellbeing across multiple domains including mood, relationships, daily activities, memory, and overall life satisfaction. The feasibility study will assess completeness of data, variability, and acceptability of QoL-AD as the primary endpoint for a future definitive RCT.
Mental Wellbeing (SWEMWBS)
Time frame: Baseline and Six Months
The Short Warwick-Edinburgh Mental Wellbeing Scale (SWEMWBS). This seven-item scale assesses emotional functioning, optimism, and psychological wellbeing. The feasibility study will evaluate suitability, recruitment, retention, and response characteristics of SWEMWBS as the primary carer outcome for the full trial.
2 secondary outcomes
Engagement and Independence in Dementia Questionnaire (EID-Q)
Time frame: Baseline and Six Months
Rosenberg Self-Esteem Scale - Brief Version (RSES)
Time frame: Baseline and Six Months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 11 Aug 2026.
- Dementianarratives.org is the LEND website that tells people about what the currently status of LEND is and what research findings have been made.Link provided by the sponsor.
- Individual participant dataSharing planned: No. Only anonymised data will be shared for the purposes of analysis and interpretation.
Related trials for Dementia
Not yet recruiting
Virtual Reality to Advance Dementia Care and Quality of Life
Dementia, Agitation
RecruitingPhase 2
Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin
Alzheimer's Disease
RecruitingObservational study
Amyloid PET Imaging in the Baltimore Longitudinal Study of Aging
Aging
Not yet recruiting
A Hybrid Effectiveness-Implementation and Cost-Utility Evaluation of a Support Programme for Informal Carers of People With Dementia in Primary Care (EsCuidar2)
Quality of Life
Recruiting
The Effects of Successful OSA Treatment on Memory and AD Biomarkers in Older Adults Study
Obstructive Sleep Apnea, Cognitive Decline
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Mark Howells contact
Martin Orrell study director
University of Nottingham
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Online LEND Intervention in people with Dementia and Neuro-Degenerative Disease, run by University of Nottingham at 2 sites in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 11 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Linda E O'Raw, PhD (07791598280, linda.o'raw@nottingham.ac.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Quality of Life (QoL-AD) (time frame: Baseline and Six Months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Aug 2026.